Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer

[1]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[2]  B. Aronow,et al.  A Thrombospondin-Dependent Pathway for a Protective ER Stress Response , 2012, Cell.

[3]  Z. Popović,et al.  Thrombospondin‐4 regulates fibrosis and remodeling of the myocardium in response to pressure overload , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  Melissa A Troester,et al.  Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients , 2012, Breast Cancer Research.

[5]  Zhiyuan Hu,et al.  Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples , 2011, BMC Medical Genomics.

[6]  Wolfgang Kemmner,et al.  THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling , 2011, Modern Pathology.

[7]  Jorge S. Reis-Filho,et al.  Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement , 2011, Journal of the National Cancer Institute.

[8]  B. Leggett,et al.  Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation , 2010, BMC Cancer.

[9]  A. Vincent-Salomon,et al.  Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma. , 2010, European journal of cancer.

[10]  I. Ellis,et al.  Lobular breast carcinoma and its variants. , 2010, Seminars in diagnostic pathology.

[11]  B. Kreike,et al.  The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type , 2010, The Journal of pathology.

[12]  Mustafa Ozen,et al.  Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer , 2009, Clinical Cancer Research.

[13]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Lawler,et al.  The effect of thrombospondin-1 on breast cancer metastasis , 2009, Breast Cancer Research and Treatment.

[15]  F. Bertucci,et al.  Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles , 2008, Oncogene.

[16]  R. Gelber,et al.  Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[18]  J. Lawler,et al.  Thrombospondins in cancer. , 2008, Cellular and molecular life sciences : CMLS.

[19]  I. Ellis,et al.  Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. , 2008, European journal of cancer.

[20]  J. Lawler,et al.  Thrombospondins: from structure to therapeutics , 2008, Cellular and Molecular Life Sciences.

[21]  Janine Senz,et al.  Hereditary diffuse gastric cancer: association with lobular breast cancer , 2007, Familial Cancer.

[22]  E. Topol,et al.  Thrombospondins, their polymorphisms, and cardiovascular disease. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[23]  R. Seruca,et al.  Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer , 2007, Journal of Clinical Pathology.

[24]  G. Turashvili,et al.  Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis , 2007, BMC Cancer.

[25]  D. Huntsman,et al.  CDH1/E-cadherin germline mutations in early-onset gastric cancer , 2006, Journal of Medical Genetics.

[26]  Alan Mackay,et al.  The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis , 2006, Breast Cancer Research.

[27]  A. Nobel,et al.  The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.

[28]  Rafael A. Irizarry,et al.  Bioinformatics and Computational Biology Solutions using R and Bioconductor , 2005 .

[29]  Howard Y. Chang,et al.  Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[31]  R. Duisters,et al.  Thrombospondin-2 Is Essential for Myocardial Matrix Integrity: Increased Expression Identifies Failure-Prone Cardiac Hypertrophy , 2004, Circulation research.

[32]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[33]  Josephine C. Adams,et al.  Functions of the conserved thrombospondin carboxy-terminal cassette in cell-extracellular matrix interactions and signaling. , 2004, The international journal of biochemistry & cell biology.

[34]  David Botstein,et al.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. , 2004, Molecular biology of the cell.

[35]  J. Thiery,et al.  Wide metastatic spreading in infiltrating lobular carcinoma of the breast. , 2004, European journal of cancer.

[36]  Ash A. Alizadeh,et al.  Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.

[37]  R. Elledge,et al.  Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome , 2004, Breast Cancer Research.

[38]  Jane Fridlyand,et al.  Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. , 2003, Cancer research.

[39]  E. Topol,et al.  Thrombospondin-4 and Its Variants: Expression and Differential Effects on Endothelial Cells , 2003, Circulation.

[40]  J. Wang-Rodriguez,et al.  Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status , 2003, Breast Cancer Research.

[41]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[42]  M. Paulsson,et al.  Thrombospondin-4 Binds Specifically to Both Collagenous and Non-collagenous Extracellular Matrix Proteins via Its C-terminal Domains* , 2000, The Journal of Biological Chemistry.

[43]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[44]  Anthony J. Guidi,et al.  Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  N. Bertin,et al.  Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. , 1997, Cancer research.

[46]  M. Granick,et al.  Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. , 1996, The Journal of surgical research.

[47]  P. Caroni,et al.  Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth , 1995, The Journal of cell biology.

[48]  F. Molemans,et al.  Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). , 1995, Genomics.

[49]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[50]  P. Delmas,et al.  Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. , 1993, Cancer research.

[51]  S. Wong,et al.  Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study. , 1992, The American journal of pathology.

[52]  P. Isaacson,et al.  Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.

[53]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.